ubenimex has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansorge, S; Faust, J; Frank, K; Kähne, T; Lendeckel, U; Neubert, K; Reinhold, D; Wex, T | 1 |
| Horikoshi, A; Hosokawa, Y; Irie, T; Ishizuka, H; Ohkubo, T; Sawada, S | 1 |
2 other study(ies) available for ubenimex and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.
Topics: CD13 Antigens; Cell Line; Cell Membrane; Cells, Cultured; DNA; Enzyme Induction; Enzyme Inhibitors; Humans; Hydroxamic Acids; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Oligopeptides; Phytohemagglutinins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Tumor Cells, Cultured | 1996 |
Effect of ubenimex on a CD5-CD13+ CLL patient with an aggressive clinical course.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; CD13 Antigens; CD5 Antigens; Humans; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 2000 |